Email:shdiahds@163.com
Phone:+1-909-839-7620
Fax:+1-909-839-7620
Click here for qusetions for this product!
Product Catalog
β–Amyloid 1-40 (C-Terminal) Antibody
Current Country :
Download PDF Datasheet
Catalogue No : BS6004
| Host | Reactivity | Size | Application | stock | price | cart |
| BS6004 | H,M,R | 200ug | WB IHC |  |
258.00 |  |
|
Contact information
|
||||||
Product
1 mg/ml in Phosphate buffered saline (PBS) with 15 mM sodium azide, approx. pH 7.2.
Purification & Purity
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE).
Specificity
β–Amyloid 1-40 antibody detects endogenous levels of β–Amyloid 1-40 protein.
Applications (Recommended Dilutions)
WB: 1:500~1:1000 IHC: 1:50~1:200
Western Blot(WB)
Western blot (WB) analysis of β–Amyloid 1-40 antibody with Beta Amyloid peptide 1-40.
Immunohistochemistry (IHC)
Immunohistochemistry (IHC) analyzes of β–Amyloid 1-40 antibody in paraffin-embedded human Alzheimer's disease brain tissue.
Storage&Stability
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Background
Proteolytic cleavage of the amyloid protein precursor (APP, also designated A4) leads to the formation of a 4 kDa Amyloidβ/A4 protein (also designatedβ–Amyloid).This protein is involved in the formation of neurofibrillary tanges and plaques that characterize the senile plaques of Alzheimer patients. Amyloid deposition is associated with a variety of neurological disorders in addition to Alzheimer’s disease, including type II diabetes and Down’s syndrome.